Advanced Centre for Treatment Research & Education in Cancer

;

Science Sparks @ ACTREC
13 ^th May 2024	Vol. No. 13 ; Issue No.630

Publications

1. Gaikwad P, Hole A, Saxena V, Choudhary S, Nath B, CM Krishna, Mukhopadhyaya R (2024). Vibrational spectroscopic detection of radiation-induced structural changes in Chironomus hemoglobin. Biochemistry and Biophysics Reports 38: 101721.

2. Tamuli B, Sharma S, Patkar M, Biswas S (2024). Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells. Cancer Reports. 7(5):e2066.
Thesis
Mayuri Bhimrao Inchanalkar. 2024. Genomewide DNA methylation in leukoplakia and oral cancers. (LIFE09201504003) (Guide: Dr. Manoj Mahimkar)

Site of the Week

Translate is a tool which allows the translation of a nucleotide (DNA/RNA) sequence to a protein sequence.

Video of the Week

Transforming small molecule cancer drug discovery for precision medicine.

Upcoming Events

12th International Pediatric Renal Tumor Biology Meeting

June 5-7, 2024

At New York, USA

International Conference on Cancer & Radiology

June 10-12, 2024

At Hampton by Hilton Rome North,Rome,Italy

Microscopy and Image Analysis

May 20-24, 2024

At IISER, Pune

Do You Know?

First RNA based Gene Expression Profiling analysis was done in 1977 by Alwine et al. using a Northern Blot.

Cancer News

Breakthrough research offers promise for developing new immune therapies for cancer

News-Medical, 09/05/2024

Scientists now know how C100 exclusively activates one arm of a specific signaling pathway (cGAS-STING) without causing inflammatory responses that could interfere with anti-tumour immunity and which may otherwise prevent therapies achieving clinical success...

Scientists discover how deadly skin cancer evades the human immune system.

MedicalXpress, 09/05/2024

The findings, demonstrate that human melanomas utilize nerve growth factor (NGF), a protein crucial for nerve development, to shield themselves from the body's immune responses. This sheds light on how these resistant melanomas camouflage themselves from immune detection...

Alectinib approved as an adjuvant treatment for lung cancer.

National Cancer Institute, 08/05/2024

Participants in the ALINA trial had tumors with changes in the ALK gene, often called ALK-positive lung cancer. Those treated with alectinib after surgery lived longer without their cancer coming back than those treated with chemotherapy after surgery, the current standard treatment...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)